Inferior vena cava diameter determines left ventricular geometry in continuous ambulatory peritoneal dialysis patients: An echocardiographic study

Nephrology Dialysis Transplantation

Volumn 18, Issue 10, 2003, Pages 2128-2133

  Toprak, Ahmet ^a   Koc, Mehmet ^a   Tezcan, Hakan ^a   Cetin Ozener, Ishak ^a   Akoglu, Emel ^a   Oktay, Ahmet ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Continuous ambulatory peritoneal dialysis; Inferior vena cava; Ventricular remodelling

Indexed keywords

ANTIHYPERTENSIVE AGENT; HEMOGLOBIN;

ADULT; ANALYSIS OF VARIANCE; ANEMIA; ARTICLE; CHRONIC KIDNEY FAILURE; CLASSIFICATION; CLINICAL OBSERVATION; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; FEMALE; GEOMETRY; HEALTH STATUS; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE WALL; HUMAN; HYPERVOLEMIA; INFERIOR CAVA VEIN; INSPIRATORY CAPACITY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; VEIN DIAMETER;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HEART FUNCTION TESTS; HEMODYNAMIC PROCESSES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PROBABILITY; REGRESSION ANALYSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME; VENA CAVA, INFERIOR; VENTRICULAR REMODELING;

EID: 0141730357     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg298     Document Type: Article

References (20)

1. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9 [Suppl]: S16-S23
2. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray D, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uremia. Nephrol Dial Transplant 1996; 11: 1277-1285
3. Koc M, Toprak A, Tezcan H, Bihorac, A, Akoglu E, Ozener IC. Uncontrolled hypertension due to volume overload contributes to higher left ventricular mass index in CAPD patients. Nephrol Dial Transplant 2002; 17: 1661-1666
4. Cheriex EC, Leunissen KML, Janssen JHA, Mooy JMV, van Hooff JP. Echocardiography of the inferior vena cava is a simple and reliable tool for estimation of dry weight in hemodialysis patients. Nephrol Dial Transplant 1989; 4: 563-568
5. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083
6. Devereux RB, Alonso DR, Lutas EM et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458
7. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987; 59: 956-960
8. Ganau A, Devereux RB, Roman MJ et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19: 1550-1558
9. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980; 33: 27-39
10. Davies SJ, Phillips L, Griffiths AM, Russell LH, Naish PF, Russell GI. What really happens to people on long-term peritoneal dialysis? Kidney Int 1998; 54: 2207-2217
11. Jaeger JQ, Mehta RL. Assessment of dry weight in hemodialysis. An Overview. J Am Soc Nephrol 1999; 10: 392-403
12. Katzarski K, Charra B, Laurent G et al. Multifrequency bioimpedance in assessment of dry weight in hemodialysis. Nephrol Dial Transplant 1996; 11 [Suppl 2]: 20-23
13. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566
14. Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol 1995; 25: 879-884
15. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 1995; 5: 2024-2031
16. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity and mortality in end-stage renal disease. Am J Kidney Dis 1996; 28: 53-61
17. Locatelli F, Conte F, Marcelli D. The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity-the experience of the Lombardy Dialysis Registry. Nephrol Dial Transplant 1998; 13: 1642-1644
18. Low-Friedrich I, Grutzmacher P, Marz W, Bergmann M, Schoeppe W. Therapy with recombinant human erythropoietin reduces cardiac size and improves cardiac function in chronic hemodialysis patients. Am J Nephrol 1991; 11: 54-60
19. Foley RN, Parfrey PS, Morgan J et al. Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int 2000; 58: 1325-1335
20. Shigematsu Y, Hamada M, Mukai M, Matsuoka H, Sumimoto T, Hiwada K. Clinical evidence for an association between left ventricular geometric adaptation and extra cardiac target organ damage in essential hypertension. J Hypertens 1995; 13: 155-160